Binospirone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 86.29.189.94 (talk) at 00:58, 13 September 2014 (→‎Synthesis). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Binospirone
Clinical data
ATC code
  • none
Identifiers
  • 8-[2-(2,3-dihydro-1,4-benzodioxin-2-ylmethylamino)ethyl]-8-azaspiro[4.5]decane-7,9-dione
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC20H26N2O4
Molar mass358.431 g/mol g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)CC2(C1)CCCC2)CCNCC3Oc4ccccc4OC3
  • InChI=1S/C20H26N2O4/c23-18-11-20(7-3-4-8-20)12-19(24)22(18)10-9-21-13-15-14-25-16-5-1-2-6-17(16)26-15/h1-2,5-6,15,21H,3-4,7-14H2
  • Key:BVMYCHKQPGEOSI-UHFFFAOYSA-N
  (verify)

Binospirone (MDL-73,005-EF) is a drug which acts as a partial agonist at 5-HT1A somatodendritic autoreceptors but as an antagonist at postsynaptic 5-HT1A receptors.[1] It has anxiolytic effects.[2]

Synthesis

Binospirone synthesis: EP0236930 

See also

References

  1. ^ Bertrand, F; Lehmann, O; Galani, R; Lazarus, C; Jeltsch, H; Cassel, JC (2001). "Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats". Pharmacology, Biochemistry, and Behavior. 68 (4): 647–60. doi:10.1016/S0091-3057(01)00448-8. PMID 11526961.
  2. ^ Moser, PC; Tricklebank, MD; Middlemiss, DN; Mir, AK; Hibert, MF; Fozard, JR (1990). "Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam". British Journal of Pharmacology. 99 (2): 343–9. doi:10.1111/j.1476-5381.1990.tb14706.x. PMC 1917389. PMID 1970269.